Mahmud Ehtisham, Smith Thomas W R, Palakodeti Vachaspathi, Zaidi Owais, Ang Lawrence, Mitchell C Robinson, Zafar Nayab, Bromberg-Marin Guilherme, Keramati Shahin, Tsimikas Sotirios
Division of Cardiovascular Medicine, School of Medicine, University of California, San Diego, California 92103-8784, USA.
JACC Cardiovasc Interv. 2008 Jun;1(3):286-92. doi: 10.1016/j.jcin.2008.03.012.
This study sought to identify angiographic parameters of favorable clinical response to renal artery stenting.
Stenting improves blood pressure (BP) control in patients with renal artery stenosis (RAS), but markers predicting a favorable clinical response are limited.
Renal perfusion was quantified in hypertensive patients (BP >or=140/90 mm Hg) without RAS by determining renal frame count (RFC) (angiographic frames [30 frames/s] for contrast to reach distal renal parenchyma after initial renal artery opacification) and renal blush grade (RBG) (0: none, 1: minimal, 2: normal, 3: hyperemic parenchymal blush). It was hypothesized that stenting unilateral RAS in hypertensive patients would result in decreased RFC and increased RBG, which might predict BP reduction.
The RFC in 17 consecutive hypertensive patients without RAS (control group) (64.4 +/- 14.2 years, 12 male, 22 kidneys) was 20.1 +/- 5.4, whereas RBG was 2.33 +/- 0.66. In 24 consecutive hypertensive patients with unilateral RAS (study group) (72.7 +/- 11.3 years, 8 male), reduced RFC (26.6 +/- 9.1 to 21.4 +/- 6.7, p < 0.001) and increased RBG (1.63 +/- 0.71 to 2.13 +/- 0.85, p = 0.03) were observed after renal stenting. At 6 months, reduced BP (systolic BP 150.6 +/- 15.6 mm Hg to 128.6 +/- 15.5 mm Hg, p < 0.001; diastolic BP 77.2 +/- 15.6 mm Hg to 68.3 +/- 10.4 mm Hg, p = 0.022) without change in number of hypertensive medications was observed. Clinical responders (systolic BP reduction >15 mm Hg) had a greater decrease in RFC (7.7 +/- 4.6 vs. 1.7 +/- 5.1, p = 0.009) and 78.6% of patients with >4 RFC decrease were responders (p = 0.024).
This study shows that quantitative indices of renal perfusion (RFC and RBG) are impaired in patients with RAS and improve after stenting, and that RFC reduction is associated with BP reduction.
本研究旨在确定肾动脉支架置入术临床疗效良好的血管造影参数。
支架置入术可改善肾动脉狭窄(RAS)患者的血压(BP)控制,但预测良好临床疗效的指标有限。
通过测定肾帧计数(RFC)(初始肾动脉显影后造影剂到达肾实质远端的血管造影帧数[30帧/秒])和肾 blush 分级(RBG)(0:无,1:轻微,2:正常,3:充血性实质 blush)对无RAS的高血压患者(BP≥140/90mmHg)的肾灌注进行量化。假设对高血压患者单侧RAS进行支架置入术会导致RFC降低和RBG升高,这可能预示着血压降低。
17例连续无RAS的高血压患者(对照组)(64.4±14.2岁,男性12例,肾脏22个)的RFC为20.1±5.4,而RBG为2.33±0.66。在24例连续单侧RAS的高血压患者(研究组)(72.7±11.3岁,男性8例)中,肾支架置入术后观察到RFC降低(从26.6±9.1降至21.4±6.7,p<0.001)和RBG升高(从1.63±0.71升至2.13±0.85,p = 0.03)。6个月时,观察到血压降低(收缩压从150.6±15.6mmHg降至128.6±15.5mmHg,p<0.001;舒张压从77.2±15.6mmHg降至68.3±10.4mmHg,p = 0.022),而高血压药物数量无变化。临床反应者(收缩压降低>15mmHg)的RFC降低幅度更大(7.7±4.6对1.7±5.1,p = 0.009),78.6%的RFC降低>4的患者为反应者(p = 0.024)。
本研究表明,RAS患者的肾灌注定量指标(RFC和RBG)受损,支架置入术后改善,且RFC降低与血压降低相关。